南京医药

600713 SSE 证监会行业分类 F51批发业

Key Metrics

Market Cap

6.8B ($982.9M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

53.7B

Net Income

743.0M

Gross Margin

N/A

Op. Margin

1.9%

Net Margin

1.4%

ROE

9.5%

ROA

2.4%

D/E

2.94

Dividend Yield

N/A

EPS

0.44

Current Ratio

1.63

Price History

Company Info

Industry	F51批发业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 南京医药

Ticker	600713
Exchange	SSE
Sector	证监会行业分类
Industry	F51批发业